Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.22.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
 3 Months Ended
Apr. 02, 2022
Apr. 03, 2021
Segment Reporting Information [Line Items]    
Revenues $ 9,324,000 $ 8,672,000
Gross profit 1,853,000 1,421,000
Operating loss (1,092,000) (2,109,000)
Depreciation and amortization 133,000 1,045,000
Total Interest expense, net 192,000 73,000
Net loss before benefit from income taxes 1,214,000 500,000
Recycling    
Segment Reporting Information [Line Items]    
Revenues 9,324,000 8,672,000
Gross profit 1,853,000 1,421,000
Operating loss (846,000) (928,000)
Depreciation and amortization 131,000 108,000
Total Interest expense, net (192,000) (73,000)
Net loss before benefit from income taxes 1,490,000 1,639,000
Biotechnology    
Segment Reporting Information [Line Items]    
Revenues 0 0
Gross profit 0 0
Operating loss (242,000) (242,000)
Depreciation and amortization 0 0
Total Interest expense, net 0 0
Net loss before benefit from income taxes (242,000) (242,000)
Technology    
Segment Reporting Information [Line Items]    
Revenues 0 0
Gross profit 0 0
Operating loss (4,000) (939,000)
Depreciation and amortization 2,000 937,000
Total Interest expense, net 0 0
Net loss before benefit from income taxes $ (34,000) $ (897,000)